Interplay between cardiac O-GlcNAcylation and cardiac dysfunction in obese diabetic mice

Jade Dron,Laurent Bultot,Alice Marino,Laura Guilbert,De Loof Marine,Sandrine Horman,Christophe Beauloye,Luc Bertrand,Natacha Fourny
DOI: https://doi.org/10.1016/j.acvd.2024.05.065
IF: 3.196
2024-06-27
Archives of Cardiovascular Diseases
Abstract:Introduction Protein O-GlcNAcylation, a post-translational modification resulting from peculiar glucose metabolism, is known to be linked to the development of diabetic cardiomyopathy. However, the molecular mechanisms involved remain largely unclear. Objective To determine the link between protein O-GlcNAcylation and the progression of the heart failure in diet-induced type 2 diabetic mice. Method Mice were subjected to high-fat (HFD) or western (WD) diet to induce obesity and diabetes over months. Cardiac hypertrophy and dysfunction were monitored by echocardiography. O-GlcNAcylation levels were assessed by western blot and mass spectrometry (MS)-based omics analysis was done to identify the proteins involved. Results Both HFD and WD induce progressive obesity and diabetes, with a more rapid and more severe metabolic alteration in HFD mice compared to WD mice. HFD and WD promote similar cardiac hypertrophy whereas cardiac dysfunction is more pronounced in WD. Protein O-GlcNAcylation levels increase significantly in WD whereas HFD promotes only a slight rise in the signal. Using MS-based approach, we identified up to 1900 O-GlcNAcylated proteins in hearts from obese animals, part of them being specific to WD group. Their bioinformatic analysis is ongoing. Conclusion HFD and WD induce different cardiac maladaptation that could be explained by different protein O-GlcNAcylation profiles.
cardiac & cardiovascular systems
What problem does this paper attempt to address?